Agile Therapeutics Inc
AGRXDelisted Jun 3, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001261249
Agile Therapeutics Inc was delisted on Jun 3, 2024; its insiders filed their last Form 4 on Aug 26, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $496.2K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 21
- Q4 2023, +4 vs. previous quarter
- 13F value
- $496.2K
- Reported value at the end of Q4 2023
- Superinvestors holding
- 0
- At the end of Q4 2023
Superinvestors holding AGRX, Q4 2023
No superinvestor reported holding AGRX at the end of Q4 2023.
Latest insider trades
Open-market purchases and sales by Agile Therapeutics Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2022 (view filing)8:30 AM ET | Aug 26 | 3 days | Altomari AlfredChief Executive Officer | PPurchase | +50.0K | $0.45 | +$22.5K | +348.6%64.3K after | |
| Oct 15, 2021 (view filing)4:05 PM ET | Oct 13 | 2 days | Edelman Joseph and 2 others10% Owner | PPurchase | +5.73M | $0.85 | +$4.87M | +36.0%21.7M after | |
| Oct 15, 2021 (view filing)4:05 PM ET | Oct 13 | 2 days | Edelman Joseph and 2 others10% Owner | PPurchase | +2.69M | – | – | –2.69M after | Derivative |
| Oct 14, 2021 (view filing) | Oct 13 | 1 day | Reilly DennisChief Financial Officer | PPurchase | +58.8K | – | – | +26.0%285.1K after | |
| Oct 14, 2021 (view filing) | Oct 13 | 1 day | Reilly DennisChief Financial Officer | PPurchase | +29.4K | – | – | –29.4K after | Derivative |
| Oct 14, 2021 (view filing) | Oct 13 | 1 day | Altomari AlfredChief Executive Officer | PPurchase | +58.8K | – | – | +11.4%573.7K after | |
| Oct 14, 2021 (view filing) | Oct 13 | 1 day | Altomari AlfredChief Executive Officer | PPurchase | +29.4K | – | – | –29.4K after | Derivative |
| Jul 29, 2021 (view filing) | Jul 29 | Same day | Altomari AlfredChief Executive Officer | PPurchase | +26.2K | $1.26 | +$33.0K | +5.4%514.9K after | |
| Jul 28, 2021 (view filing) | Jul 27 | 1 day | Reilly DennisChief Financial Officer | PPurchase | +50.0K | $1.08 | +$54.0K | +28.4%226.3K after |
Top 10 13F holders, Q4 2023
The largest institutional positions in Agile Therapeutics Inc at the end of Q4 2023; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 108,000 | $210.6K | 0.01% | +10,000+10.2% | Added |
| Renaissance Technologies LLC | 59,200 | $115.0K | 0.00% | +59,200 | New |
| Vanguard Group Inc | 20,477 | $39.9K | 0.00% | +20,477 | New |
| Citadel Advisors LLC | 19,247 | $37.5K | 0.00% | +6,422+50.1% | Added |
| Geode Capital Management, LLC | 13,748 | $26.8K | 0.00% | −42−0.3% | Reduced |
| State Street Corp | 10,843 | $21.1K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 7,712 | $15.0K | 0.00% | +4,243+122.3% | Added |
| BlackRock Inc. | 5,745 | $11.2K | 0.00% | −295−4.9% | Reduced |
| Tower Research Capital LLC (TRC) | 3,276 | $6.39K | 0.00% | +1,085+49.5% | Added |
| Advisory Services Network, LLC | 2,020 | $3.94K | 0.00% | +2,020 | New |
Holders of 5% or more of AGRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Agile Therapeutics Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Mastrangeli Doug | 13G | 5.10%350.0K shares | New | Aug 26, 20241 filing | Aug 26, 2024 | SEC |